Berman Capital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Berman Capital Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$34K	Buy
2021 Q2	$17K	Buy
2021 Q1	$12K	Buy